Clinical trial
Interest of the IRAP (Insulin Regulated Amino Peptidase) Marker to Assess the Levels of Insulin Resistance in a Cohort of Insulin-resistant Subjects Due to DUNNIGAN Lipodystrophy
NCT04578379 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Réunion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of the IRAP (Insulin Regulated Amino Peptidase) Marker to Assess the Levels of Insulin Resistance in a Cohort of Insulin-resistant Subjects Due to DUNNIGAN Lipodystrophy
- Lead sponsor
- Centre Hospitalier Universitaire de la Réunion
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2019
- Completion date
- July 1, 2020
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.